Clover Health Investments (NASDAQ:CLOV) Stock Price Up 8% – Should You Buy?

Clover Health Investments, Corp. (NASDAQ:CLOVGet Free Report) was up 8% during trading on Tuesday . The company traded as high as $3.68 and last traded at $3.65. Approximately 7,345,603 shares were traded during mid-day trading, an increase of 47% from the average daily volume of 4,991,149 shares. The stock had previously closed at $3.38.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently weighed in on the stock. UBS Group started coverage on shares of Clover Health Investments in a research report on Monday, October 7th. They issued a “neutral” rating and a $4.00 price target for the company. Craig Hallum started coverage on shares of Clover Health Investments in a research report on Tuesday, December 17th. They issued a “buy” rating and a $6.00 price target for the company.

Get Our Latest Research Report on CLOV

Clover Health Investments Trading Up 6.8 %

The company has a market capitalization of $1.81 billion, a PE ratio of -18.05 and a beta of 1.95. The firm has a 50 day simple moving average of $3.41 and a two-hundred day simple moving average of $2.86.

Clover Health Investments (NASDAQ:CLOVGet Free Report) last issued its quarterly earnings results on Wednesday, November 6th. The company reported ($0.02) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.03) by $0.01. The business had revenue of $330.99 million for the quarter, compared to analyst estimates of $347.60 million. Clover Health Investments had a negative net margin of 5.92% and a negative return on equity of 25.46%. During the same period in the previous year, the business posted ($0.09) earnings per share. Research analysts expect that Clover Health Investments, Corp. will post -0.12 earnings per share for the current fiscal year.

Institutional Trading of Clover Health Investments

A number of institutional investors have recently added to or reduced their stakes in the stock. Concurrent Investment Advisors LLC acquired a new position in shares of Clover Health Investments during the 3rd quarter worth $28,000. Sigma Planning Corp acquired a new position in Clover Health Investments during the third quarter worth about $29,000. Parallax Volatility Advisers L.P. purchased a new stake in shares of Clover Health Investments in the third quarter valued at about $38,000. Realta Investment Advisors acquired a new stake in shares of Clover Health Investments in the third quarter valued at approximately $44,000. Finally, Forum Financial Management LP increased its stake in shares of Clover Health Investments by 33.8% during the 3rd quarter. Forum Financial Management LP now owns 16,077 shares of the company’s stock worth $45,000 after purchasing an additional 4,061 shares in the last quarter. Hedge funds and other institutional investors own 19.77% of the company’s stock.

About Clover Health Investments

(Get Free Report)

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat.

Read More

Receive News & Ratings for Clover Health Investments Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clover Health Investments and related companies with MarketBeat.com's FREE daily email newsletter.